Evidence map›Paper›PMID 41538057›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer.

Simerjeet Kaur Chahal, Atul Kabra, Abdulaziz S Saeedan, Mohd Nazam Ansari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Impact of Oxidative Stress-Driven Ferroptosis in Neurodegeneration.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Simerjeet Kaur ChahalDepartment of Pharmacology, University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India.
Atul KabraDepartment of Pharmacology, University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India.
Abdulaziz S SaeedanDepartment of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Mohd Nazam AnsariDepartment of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. m.ansari@psau.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fisetin is a naturally occurring dietary flavonoid that is abundant in fruits and vegetables such as strawberries, apples, and onions. It has gained significant scholarly attention owing to its broad pharmacological prospects. This compound exhibits robust antioxidant and anti-inflammatory activities and has notable anticancer and neuroprotective effects. Fisetin strongly modulates key cellular signaling pathways, induces apoptosis, and inhibits tumor growth, thus protecting cells against oxidative damage and neurodegenerative events. Additional hepatoprotective, antiviral, and gastroprotective actions further highlight the therapeutic importance of this compound. This review presents an integrated and detailed analysis of the pharmacokinetics, diverse biological activities, and molecular mechanisms of action of fisetin underlying its therapeutic actions. It also assesses its toxicological profile, including safety considerations such as genotoxicity at relatively high concentrations. Poor solubility and low bioavailability are key limitations, along with emerging formulation methods designed to facilitate its clinical utility. Furthermore, this review synthesizes evidence from ongoing trials and outlines future priorities. Collectively, these findings position fisetin as a promising therapeutic candidate with potential across a wide range of disease conditions.

Indexed as

AgingAnti-Inflammatory AgentsAntioxidantsFlavonoidsFlavonolsNeoplasmsAnimalsHumansInflammationNeuroprotective AgentsOxidative StressAnti-Inflammatory AgentsAntioxidantsfisetinFlavonoidsFlavonolsNeuroprotective AgentsAntioxidantFisetinFlavonolNeuroprotectionPharmacological properties

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.